Baofeng Guo

1.4k total citations
57 papers, 1.1k citations indexed

About

Baofeng Guo is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Baofeng Guo has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Biomedical Engineering. Recurrent topics in Baofeng Guo's work include RNA Interference and Gene Delivery (12 papers), Nanoplatforms for cancer theranostics (10 papers) and Cancer Research and Treatments (10 papers). Baofeng Guo is often cited by papers focused on RNA Interference and Gene Delivery (12 papers), Nanoplatforms for cancer theranostics (10 papers) and Cancer Research and Treatments (10 papers). Baofeng Guo collaborates with scholars based in China, United States and Thailand. Baofeng Guo's co-authors include Xuejian Zhao, Libo Xu, Ling Zhang, Ding Wang, Dennis J. Kopecko, De-Qi Xu, Di Yin, Yang Li, Xin Li and Dhan V. Kalvakolanu and has published in prestigious journals such as Cancer Research, Coordination Chemistry Reviews and Biochemical and Biophysical Research Communications.

In The Last Decade

Baofeng Guo

55 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baofeng Guo China 19 513 329 235 185 175 57 1.1k
Hui Gao China 22 736 1.4× 182 0.6× 110 0.5× 181 1.0× 304 1.7× 50 1.2k
Vadim S. Pokrovsky Russia 21 646 1.3× 85 0.3× 288 1.2× 128 0.7× 171 1.0× 111 1.2k
Anabel Sorolla Spain 22 791 1.5× 144 0.4× 85 0.4× 262 1.4× 187 1.1× 49 1.3k
Stephen M. Stribbling United Kingdom 18 655 1.3× 120 0.4× 169 0.7× 278 1.5× 150 0.9× 25 1.0k
Leiming Xu China 17 362 0.7× 258 0.8× 48 0.2× 193 1.0× 196 1.1× 43 1.0k
X Chen China 20 781 1.5× 112 0.3× 116 0.5× 435 2.4× 168 1.0× 58 1.3k
Deepak B. Thimiri Govinda Raj Norway 18 651 1.3× 108 0.3× 78 0.3× 401 2.2× 101 0.6× 65 1.3k
Chengheng Liao United States 18 550 1.1× 123 0.4× 51 0.2× 143 0.8× 277 1.6× 24 874
Ling Yu China 19 452 0.9× 231 0.7× 48 0.2× 321 1.7× 85 0.5× 44 1.1k

Countries citing papers authored by Baofeng Guo

Since Specialization
Citations

This map shows the geographic impact of Baofeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baofeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baofeng Guo more than expected).

Fields of papers citing papers by Baofeng Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baofeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baofeng Guo. The network helps show where Baofeng Guo may publish in the future.

Co-authorship network of co-authors of Baofeng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Baofeng Guo. A scholar is included among the top collaborators of Baofeng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baofeng Guo. Baofeng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Mengxin, Xuanzhong Wang, Baofeng Guo, et al.. (2025). Transglutaminase 2 promotes breast cancer cell autophagy by targeting p53/ mTOR axis. Biochemical Pharmacology. 237. 116926–116926.
2.
Yang, Xin, Jiaying Yang, Qian Luo, et al.. (2025). Multifunctional nanozymes: Promising applications in clinical diagnosis and cancer treatment. Biosensors and Bioelectronics. 279. 117383–117383. 3 indexed citations
3.
Mao, Binli, Vu Thuy Khanh Le‐Trilling, Jie Hu, et al.. (2024). Diphyllin elicits a doubled-pronged attack on the entry of SARS-CoV-2 by inhibiting cathepsin L and furin. Virus Research. 350. 199485–199485. 1 indexed citations
4.
Yang, Xing, et al.. (2024). A scientometric analysis of immunotherapies for gliomas: Focus on GBM. Asian Journal of Surgery. 47(10). 4271–4280. 3 indexed citations
5.
Yang, Xing, Mei Yang, Yajie Du, et al.. (2023). A scientometric analysis and up-to-date review of nano-based drug delivery systems in glioblastoma treatment. Nano Today. 52. 101961–101961. 16 indexed citations
6.
Xu, Libo, Ling Zhang, Shengnan Zhang, et al.. (2023). Taxifolin inhibits melanoma proliferation/migration impeding USP18/Rac1/JNK/β-catenin oncogenic signaling. Phytomedicine. 123. 155199–155199. 8 indexed citations
7.
Xu, Libo, Ling Zhang, Jicheng Sun, et al.. (2022). Roles for the methyltransferase SETD8 in DNA damage repair. Clinical Epigenetics. 14(1). 34–34. 12 indexed citations
8.
Wang, Ding, Xiaodong Wei, Qian Wang, et al.. (2021). GRIM-19 inhibits proliferation and induces apoptosis in a p53-dependent manner in colorectal cancer cells through the SIRT7/PCAF/MDM2 axis. Experimental Cell Research. 407(1). 112799–112799. 10 indexed citations
9.
Wang, Qian, Shengnan Jia, Ding Wang, et al.. (2020). A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling Axis. Molecular Cancer Therapeutics. 19(12). 2542–2553. 25 indexed citations
10.
Liang, Hang, Qian Wang, Ding Wang, et al.. (2020). RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7. Biochemical Pharmacology. 180. 114118–114118. 14 indexed citations
11.
Zhao, Yanying, Libo Xu, Baofeng Guo, et al.. (2018). Synergistic Suppression of Melanoma Growth by a Combination of Natural dsRNA and Panaxadiolsaponins. Journal of Interferon & Cytokine Research. 38(9). 378–387. 1 indexed citations
12.
Xu, Libo, Jinguo Wang, Baofeng Guo, et al.. (2017). Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China. Oncotarget. 9(1). 428–441. 11 indexed citations
13.
14.
Klingler, Stefan, Baofeng Guo, Jun Yao, et al.. (2015). Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms. Cancer Research. 75(10). 2109–2119. 29 indexed citations
15.
Li, Xin, Yang Li, Jiadi Hu, et al.. (2013). Plasmid-based E6-specific siRNA and co-expression of wild-type p53 suppresses the growth of cervical cancer in vitro and in vivo. Cancer Letters. 335(1). 242–250. 20 indexed citations
16.
Ye, Yiyi, Xianghui Han, Baofeng Guo, Zhenping Sun, & Sheng Liu. (2013). Combination treatment with platycodin D and osthole inhibits cell proliferation and invasion in mammary carcinoma cell lines. Environmental Toxicology and Pharmacology. 36(1). 115–124. 35 indexed citations
17.
Li, Xiaojie, Ling Zhang, Yueting Shao, et al.. (2011). Effects of a human plasma membrane-associated sialidase siRNA on prostate cancer invasion. Biochemical and Biophysical Research Communications. 416(3-4). 270–276. 18 indexed citations
18.
Guo, Baofeng, Yang Li, Xiaojie Li, et al.. (2011). Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo. Asian Journal of Andrology. 13(3). 481–486. 32 indexed citations
19.
Zhao, Lijing, Dongxu Zhao, Guimiao Lin, et al.. (2009). Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3. Cancer Gene Therapy. 17(3). 171–179. 27 indexed citations
20.
Zhang, Ling, Lifang Gao, Lijuan Zhao, et al.. (2007). Intratumoral Delivery and Suppression of Prostate Tumor Growth by Attenuated Salmonella enterica serovar typhimurium Carrying Plasmid-Based Small Interfering RNAs. Cancer Research. 67(12). 5859–5864. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hui Gao Breakdown of academic impact, for papers by Vadim S. Pokrovsky Breakdown of academic impact, for papers by Anabel Sorolla Breakdown of academic impact, for papers by Stephen M. Stribbling Breakdown of academic impact, for papers by Leiming Xu Breakdown of academic impact, for papers by X Chen Breakdown of academic impact, for papers by Deepak B. Thimiri Govinda Raj Breakdown of academic impact, for papers by Chengheng Liao Breakdown of academic impact, for papers by Ling Yu
Rankless by CCL
2026